ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Themis Medicare Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹89.74 cr (+15.1% YoY), EBITDA ₹5.58 cr (6.2% margin) turned positive, PAT ₹7.06 cr vs prior loss. API rebound and hospital focus.

Highlights
Revenue growthQ2 +15.1% YoY; H1 +0.6% YoY
MarginsQ2 EBITDA margin 6.2% vs -3.96% YoY; gross margin down
Demand visibilityAPI: healthy revenue visibility; overseas molecule talks ongoing
Management confidenceUpbeat on H2; no quantified targets

Growth

Q2 revenue +15.1% YoY, API +71%. H1 revenue flat (+0.6%); H1 PAT inflated by ₹92.95 cr one-off share-sale gain.

Outlook

No numeric guidance. Management expects H2 optimism; pursuing overseas API molecules; RoW expansion in 0–3 yrs, EU/USA in 3–5 yrs.

Risks

Gross margin hit by inventory price adjustment and one-offs; H1 EBITDA loss ₹46.84 cr after Q1 ₹52.42 cr loss.

Source

Investor Presentation filed with BSE, NSE: THEMISMED. Summary written with AI assistance from the document.

Read the document ↗

Themis Medicare Ltd: key numbers

Share price
₹96.49
Market cap
₹888.7 Cr
Revenue (annual)
₹342.2 Cr
Net profit (annual)
₹1.14 Cr
P/E (TTM)
17.6×Sector 48.6×
Promoter holding
67.11%+0.00% QoQ
FII holding
0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Themis Medicare Ltd

All →